2019 Pharmaceutical Industry and Regulators Symposium Recording - Day 1, Part 4
This video is a recording of the fourth two presentations given at the 2019 Pharmaceutical Industry and Regulators Symposium in May 2019.
Presentation 1: (Q)SAR Evaluation of Drug Impurities from the US FDA Scientific Perspective.
Dr. Naomi Kruhlak, FDA
Presentation 2: Round table discussion and concluding remarks on ICH M7.
Dr. Chris Barber, Lhasa Limited, CEO
Antonio Oliveira, PHD